Clinical Trials Logo

Clinical Trial Summary

Danon disease (DD) is a rare, X-linked disorder associated with severe cardiomyopathy, and in many cases, skeletal myopathy, and cognitive impairment caused by mutations in the LAMP2 gene. There is still uncertainty regarding the natural history of DD because of its rarity. This study aims to determine the natural history of DD through the collection and analysis of retrospective and prospective data. To achieve this, the investigators will perform surveys and obtain medical records from DD patients. The same cohort of patients will also be assessed by a multidisciplinary team with expertise in DD (cardiologist, neurologist, ophthalmologist, psychologist, geneticist) at the University of California, San Diego. All patients with DD are eligible, including those who underwent a heart transplant. Additionally, data and records from deceased patients will provide valuable retrospective data for this study.


Clinical Trial Description

The study design will include: 1. Collection of information for all patients from: - Survey of patient or caregiver (if the patient has deceased) - Medical Charts 2. Collection of information from living patients assessed by the multidisciplinary team at the University of California, San Diego including: - A complete medical history and physical examination - Cardiac Testing (Electrocardiography; Echocardiography; Cardiac magnetic resonance imaging with gadolinium contrast agent-gadolinium contrast is optional-; Cardiopulmonary Test) - Pulmonary function testing (PFT) - Neuromuscular Assessment - Cognitive Tests - Vision exam including retinal evaluation - Laboratory Tests - Questionnaires on Quality of life - Needle Skeletal muscle biopsy (only for patients over 18 years old) - Abdominal Ultrasound for assessment of the liver structure ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03766386
Study type Observational [Patient Registry]
Source University of California, San Diego
Contact Eric Adler, MD
Phone 8582462996
Email eradler@ucsd.edu
Status Recruiting
Phase
Start date November 30, 2018
Completion date November 2024

See also
  Status Clinical Trial Phase
Recruiting NCT06092034 - A Multi-Center, Open Label Gene Therapy Study of RP-A501 in Male Patients With Danon Disease Phase 2
Completed NCT05548855 - Natural History of Danon Disease
Recruiting NCT06214507 - Danon Disease Natural History Study
Active, not recruiting NCT03882437 - Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B Phase 1